• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的临床病理特征使分化型甲状腺癌患者易发生不同模式的远处转移,并伴有异质性的短期预后。

Different clinicopathologic features predispose to different patterns of distant metastasis with heterogeneous short-term prognosis in patients with differentiated thyroid cancer.

作者信息

Tan Li-Cheng, Huang Nai-Si, Yu Peng-Cheng, Han Pei-Zhen, Liu Wan-Lin, Lu Zhong-Wu, Shi Rong-Liang, Shi Xiao, Wang Yu, Ji Qing-Hai, Qu Ning, Wei Wen-Jun, Wang Yu-Long

机构信息

Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Clin Endocrinol (Oxf). 2022 Mar;96(3):402-412. doi: 10.1111/cen.14602. Epub 2021 Sep 30.

DOI:10.1111/cen.14602
PMID:34592016
Abstract

BACKGROUND

Limited studies have focused on the associated clinicopathologic features and short-term prognostic impacts of metastatic patterns at initial diagnosis in differentiated thyroid cancer (DTC).

METHODS

Overall, 530 individuals with distant DTC diagnosed between 2010 and 2014 were identified from Surveillance, Epidemiology, and End Results (SEER) database. Multinomial logistic regression model was used to assess the clinicopathologic factors influencing the pattern of distant metastasis. Kaplan-Meier method and multivariable Cox regression were used to estimate the short-term effects of metastatic patterns on overall (OS) and thyroid cancer-specific survival (TCSS).

RESULTS

Fifty, 111, 263, 59 and 47 patients presented with distant lymph node (LN)-only, bone-only, lung-only, bone plus lung, and liver and/or brain metastases (Mets), respectively. Regional lymph node metastasis (LNM) and follicular histotype were the only confirmed risk factors for distant LN-only Mets and bone-only Mets, respectively. Larger tumour size, extrathyroidal extension (ETE) and papillary histotype were associated with lung-only Mets. Synchronous bone and lung Mets were more likely to occur in older patients. In addition, patients with distant LN-only Mets had hardly any negative effect on OS and TCSS, whereas those with synchronous bone and lung or liver/brain Mets predicted unfavourable short-term outcomes, regardless of whether they received total thyroidectomy and radioisotopes.

CONCLUSIONS

Different clinicopathologic factors predispose to different patterns of metastases with profound short-term survival differences among DTC patients. Our findings may help to determine effective pretreatment screening for aggressive metastatic patterns at initial diagnosis, and thus to provide additional treatment or access of clinical trials for these patients.

摘要

背景

关于分化型甲状腺癌(DTC)初诊时转移模式的相关临床病理特征及短期预后影响的研究有限。

方法

总体而言,从监测、流行病学和最终结果(SEER)数据库中识别出2010年至2014年间诊断为远处转移DTC的530例患者。采用多项逻辑回归模型评估影响远处转移模式的临床病理因素。采用Kaplan-Meier法和多变量Cox回归估计转移模式对总生存期(OS)和甲状腺癌特异性生存期(TCSS)的短期影响。

结果

分别有50例、111例、263例、59例和47例患者出现仅远处淋巴结转移(LN)、仅骨转移、仅肺转移、骨加肺转移以及肝和/或脑转移。区域淋巴结转移(LNM)和滤泡组织学类型分别是仅远处LN转移和仅骨转移的唯一确定危险因素。肿瘤体积较大、甲状腺外侵犯(ETE)和乳头状组织学类型与仅肺转移有关。同步骨和肺转移更可能发生在老年患者中。此外,仅远处LN转移的患者对OS和TCSS几乎没有负面影响,而同步骨和肺或肝/脑转移的患者则预示着短期预后不良,无论他们是否接受了甲状腺全切术和放射性同位素治疗。

结论

不同的临床病理因素易导致不同的转移模式,DTC患者之间存在明显的短期生存差异。我们的研究结果可能有助于确定初诊时侵袭性转移模式的有效预处理筛查,从而为这些患者提供额外的治疗或临床试验机会。

相似文献

1
Different clinicopathologic features predispose to different patterns of distant metastasis with heterogeneous short-term prognosis in patients with differentiated thyroid cancer.不同的临床病理特征使分化型甲状腺癌患者易发生不同模式的远处转移,并伴有异质性的短期预后。
Clin Endocrinol (Oxf). 2022 Mar;96(3):402-412. doi: 10.1111/cen.14602. Epub 2021 Sep 30.
2
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.分化型甲状腺癌伴骨转移患者的长期预后和预测因素。
Endocr Pract. 2019 May;25(5):427-437. doi: 10.4158/EP-2018-0465. Epub 2019 Jan 18.
3
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.分化型甲状腺癌伴远处转移患者的长期预后及预后因素
Endocr Pract. 2017 Oct;23(10):1193-1200. doi: 10.4158/EP171924.OR. Epub 2017 Jul 13.
4
Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.临床特征辅助的 1-4cm 单发甲状腺内分化型甲状腺癌甲状腺切除术范围的危险分层。
Front Endocrinol (Lausanne). 2022 Feb 8;12:790730. doi: 10.3389/fendo.2021.790730. eCollection 2021.
5
Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992-2018.美国 1992-2018 年分化型甲状腺癌伴远处转移患者的疾病特异性生存趋势。
Thyroid. 2023 Jan;33(1):63-73. doi: 10.1089/thy.2022.0353. Epub 2022 Nov 18.
6
Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.转移性淋巴结负担对甲状腺乳头状癌各亚型远处转移的预测影响。
Thyroid. 2021 Oct;31(10):1549-1557. doi: 10.1089/thy.2021.0131.
7
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.美国分化型甲状腺癌的AMES预后指数与甲状腺切除范围
Surgery. 2004 Sep;136(3):609-16. doi: 10.1016/j.surg.2003.12.009.
8
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
9
Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.沙特阿拉伯小儿分化型甲状腺癌远处转移的预测性危险因素。
Front Endocrinol (Lausanne). 2023 Oct 6;14:1228049. doi: 10.3389/fendo.2023.1228049. eCollection 2023.
10
Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.分化型甲状腺癌远处转移老年患者(≥65 岁)接受碘 131 治疗及随访后的长期结局和预后。
Front Endocrinol (Lausanne). 2021 Feb 25;11:588024. doi: 10.3389/fendo.2020.588024. eCollection 2020.

引用本文的文献

1
Clinical Risk Factor for Detected Distant Metastasis and Anaplastic Transformation After Reoperation in Recurrent/Persistent Differentiated Thyroid Cancer: A Retrospective Cohort Study.复发性/持续性分化型甲状腺癌再次手术后远处转移和间变转化的临床危险因素:一项回顾性队列研究
Laryngoscope Investig Otolaryngol. 2025 Aug 7;10(4):e70230. doi: 10.1002/lio2.70230. eCollection 2025 Aug.
2
Impact of distant metastasis on overall survival and cancer specific survival of elderly patients with differentiated thyroid cancer.远处转移对老年分化型甲状腺癌患者总生存和癌症特异性生存的影响。
Sci Rep. 2024 Oct 22;14(1):24855. doi: 10.1038/s41598-024-76613-5.
3
Establishment and verification of the first prognostic nomograms in locally advanced thyroid cancer based on the analysis of clinical and follow-up information on 2396 patients.
基于对2396例患者的临床和随访信息分析,建立并验证首个局部晚期甲状腺癌预后列线图。
Heliyon. 2024 Jan 30;10(3):e24798. doi: 10.1016/j.heliyon.2024.e24798. eCollection 2024 Feb 15.
4
A High-Quality Nomogram for Predicting Lung Metastasis in Newly Diagnosed Stage IV Thyroid Cancer: A Population-Based Study.高质量列线图预测新诊断 IV 期甲状腺癌肺转移:一项基于人群的研究。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231167807. doi: 10.1177/15330338231167807.
5
Oligometastatic disease from differentiated thyroid cancer: best treatment schemes.分化型甲状腺癌寡转移病灶:最佳治疗方案。
Curr Opin Oncol. 2023 Jan 1;35(1):15-21. doi: 10.1097/CCO.0000000000000921. Epub 2022 Nov 21.
6
Bone metastases in newly diagnosed patients with thyroid cancer: A large population-based cohort study.新诊断甲状腺癌患者的骨转移:一项基于大人群的队列研究。
Front Oncol. 2022 Aug 12;12:955629. doi: 10.3389/fonc.2022.955629. eCollection 2022.
7
Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer.吲哚胺2,3-双加氧酶免疫状态作为晚期远处转移性分化型甲状腺癌放射性碘疗效的潜在生物标志物
Front Oncol. 2022 Jul 18;12:871792. doi: 10.3389/fonc.2022.871792. eCollection 2022.